A Yale researcher has partnered with Novartis to develop an RNA vaccine to protect against the malaria parasite, reported Yale News.
According to the Yale research team, if the Malaria vaccine candidate is approved, it could be revolutionary to the pharmaceutical field.
The RTS,S vaccine, which was developed about two and a half years ago, grants about 30% protection, which decreases very quickly in about two to three years, said this Yale article written by Beatriz Horta.
Read More
